Suppr超能文献

利用肺龄概念激励医院肺功能实验室中的吸烟者戒烟。

Motivating smokers in the hospital pulmonary function laboratory to quit smoking by use of the lung age concept.

机构信息

Department of Medicine, Division of Pulmonary Disease and Critical Care Medicine, University of Vermont, Burlington, VT 05405, USA.

出版信息

Nicotine Tob Res. 2011 Nov;13(11):1161-6. doi: 10.1093/ntr/ntr096. Epub 2011 May 6.

Abstract

INTRODUCTION

The purpose of this study was to investigate the use of lung age to motivate a quit attempt among smokers presenting to a hospital pulmonary function testing (PFT) laboratory.

METHODS

Participants were randomized to receive a lung age-based motivational strategy (intervention group) versus standard care (control group). At 1 month, all participants were interviewed by telephone to determine whether they made a quit attempt.

RESULTS

A total of 67 participants were enrolled, and 51 completed the study. Baseline mean data included age = 52 years, 70% women, 40 pack-years of smoking, FEV(1) = 69% predicted, and lung age = 83 years. The quit attempt rates were not different between the intervention and control groups (32% vs. 24%, respectively, p = .59). There was a near significant interaction between lung age and intervention strategy (p = .089), with quit attempt rates among those with normal lung age of 18% in the intervention group versus 33% in the control group and among those with high (worse) lung age of 39% in the intervention group versus 17% in the control group; p = .38.

CONCLUSIONS

Using lung age to motivate smokers presenting to the PFT laboratory to quit may succeed in patients with high lung age but may undermine motivation in smokers with normal lung age. Further work is needed to refine the approach to smokers with normal lung age.

摘要

简介

本研究旨在调查使用肺龄来激励到医院肺功能检测(PFT)实验室就诊的吸烟者尝试戒烟。

方法

参与者被随机分配接受基于肺龄的激励策略(干预组)或标准护理(对照组)。在 1 个月时,所有参与者均通过电话进行访谈,以确定他们是否尝试戒烟。

结果

共纳入 67 名参与者,其中 51 名完成了研究。基线平均数据包括年龄为 52 岁,女性占 70%,吸烟 40 包年,FEV1 为预计值的 69%,肺龄为 83 岁。干预组和对照组的戒烟尝试率无差异(分别为 32%和 24%,p =.59)。肺龄和干预策略之间存在显著的交互作用(p =.089),在干预组中,肺龄正常的参与者的戒烟尝试率为 18%,而对照组为 33%;在干预组中,肺龄较高(较差)的参与者的戒烟尝试率为 39%,而对照组为 17%;p =.38。

结论

使用肺龄来激励到 PFT 实验室就诊的吸烟者戒烟可能对肺龄较高的患者有效,但可能会削弱肺龄正常的吸烟者的戒烟动机。需要进一步研究来完善针对肺龄正常的吸烟者的方法。

相似文献

1
Motivating smokers in the hospital pulmonary function laboratory to quit smoking by use of the lung age concept.
Nicotine Tob Res. 2011 Nov;13(11):1161-6. doi: 10.1093/ntr/ntr096. Epub 2011 May 6.
4
Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial.
BMJ. 2008 Mar 15;336(7644):598-600. doi: 10.1136/bmj.39503.582396.25. Epub 2008 Mar 6.
6
Smoking Cessation in the ITALUNG Lung Cancer Screening: What Does "Teachable Moment" Mean?
Nicotine Tob Res. 2020 Aug 24;22(9):1484-1491. doi: 10.1093/ntr/ntz148.
7
Effects of motivation phase intervention components on quit attempts in smokers unwilling to quit: A factorial experiment.
Drug Alcohol Depend. 2019 Apr 1;197:149-157. doi: 10.1016/j.drugalcdep.2019.01.011. Epub 2019 Feb 16.
8
A Randomized Trial of Motivational Interviewing: Cessation Induction Among Smokers With Low Desire to Quit.
Am J Prev Med. 2016 May;50(5):573-583. doi: 10.1016/j.amepre.2015.10.013. Epub 2015 Dec 23.

引用本文的文献

2
'Skeletal Age' for mapping the impact of fracture on mortality.
Elife. 2023 May 16;12:e83888. doi: 10.7554/eLife.83888.
3
Spirometry and Smoking Cessation in Primary Care: The ESPIROTAB STUDY, A Randomized Clinical Trial.
Int J Environ Res Public Health. 2022 Nov 6;19(21):14557. doi: 10.3390/ijerph192114557.
4
5
Self-Reported Smoking Status 10-Months After a Single Session Intervention Including an Education Conference About Smoking Harms and Announcement of Spirometric Lung-Age.
Clin Med Insights Circ Respir Pulm Med. 2021 Oct 20;15:11795484211047041. doi: 10.1177/11795484211047041. eCollection 2021.
6
Comparative Analysis of Three Different Drug Distribution Schemes for Smoking Cessation.
Turk Thorac J. 2021 Mar;22(2):110-117. doi: 10.5152/TurkThoracJ.2020.19111. Epub 2021 Mar 1.
8
Spirometry to increase smoking cessation rate: A systematic review.
Tob Induc Dis. 2019 Apr 17;17:31. doi: 10.18332/tid/106090. eCollection 2019.
9
Biomedical risk assessment as an aid for smoking cessation.
Cochrane Database Syst Rev. 2019 Mar 26;3(3):CD004705. doi: 10.1002/14651858.CD004705.pub5.
10
How old are you, really? Communicating chronic risk through 'effective age' of your body and organs.
BMC Med Inform Decis Mak. 2016 Aug 5;16:104. doi: 10.1186/s12911-016-0342-z.

本文引用的文献

1
Smoking cessation and development of respiratory health in smokers screened with normal spirometry.
Respir Med. 2011 Feb;105(2):243-9. doi: 10.1016/j.rmed.2010.07.010. Epub 2010 Sep 17.
2
Should we use 'lung age'?
Prim Care Respir J. 2010 Sep;19(3):197-9. doi: 10.4104/pcrj.2010.00045.
4
Motivational interviewing for smoking cessation.
Cochrane Database Syst Rev. 2010 Jan 20(1):CD006936. doi: 10.1002/14651858.CD006936.pub2.
5
Smoking cessation: the potential role of risk assessment tools as motivational triggers.
Postgrad Med J. 2010 Jan;86(1011):26-33; quiz 31-2. doi: 10.1136/pgmj.2009.084947.
6
Biomedical risk assessment as an aid for smoking cessation.
Cochrane Database Syst Rev. 2009 Apr 15(2):CD004705. doi: 10.1002/14651858.CD004705.pub3.
7
What mediates the effect of confrontational counselling on smoking cessation in smokers with COPD?
Patient Educ Couns. 2009 Jul;76(1):16-24. doi: 10.1016/j.pec.2008.11.017. Epub 2009 Jan 16.
8
Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial.
BMJ. 2008 Mar 15;336(7644):598-600. doi: 10.1136/bmj.39503.582396.25. Epub 2008 Mar 6.
10
Spirometric screening: Does it work?
Thorax. 2006 Oct;61(10):834-5. doi: 10.1136/thx.2006.061317.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验